Nova Cannabis Inc.
NVACF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $259 | $226 | $134 | $21 |
| % Growth | 14.5% | 68.5% | 539.2% | – |
| Cost of Goods Sold | $209 | $183 | $109 | $15 |
| Gross Profit | $50 | $44 | $25 | $6 |
| % Margin | 19.4% | 19.4% | 18.5% | 30.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $33 | $32 | $7 | $2 |
| SG&A Expenses | $38 | $32 | $28 | $13 |
| Sales & Mktg Exp. | $5 | $0 | $21 | $11 |
| Other Operating Expenses | $13 | $0 | $0 | -$2 |
| Operating Expenses | $40 | $48 | $38 | $13 |
| Operating Income | $10 | -$8 | -$18 | -$6 |
| % Margin | 3.8% | -3.3% | -13.4% | -30.1% |
| Other Income/Exp. Net | -$5 | -$4 | -$3 | -$2 |
| Pre-Tax Income | $3 | -$11 | -$21 | -$9 |
| Tax Expense | $0 | $0 | $0 | -$1 |
| Net Income | $3 | -$11 | -$21 | -$9 |
| % Margin | 1.2% | -4.9% | -15.3% | -44.1% |
| EPS | 0.053 | -0.2 | -0.39 | -1.28 |
| % Growth | 126.5% | 48.7% | 69.5% | – |
| EPS Diluted | 0.053 | -0.2 | -0.39 | -1.28 |
| Weighted Avg Shares Out | 57 | 57 | 52 | 7 |
| Weighted Avg Shares Out Dil | 57 | 57 | 52 | 7 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $3 | $0 |
| Interest Expense | $5 | $4 | $3 | $1 |
| Depreciation & Amortization | $11 | $11 | $10 | $6 |
| EBITDA | $19 | $4 | -$7 | $6 |
| % Margin | 7.3% | 1.6% | -5.6% | 26.3% |